These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27704139)

  • 1. Pigmy MicroRNA: surveillance cops in Therapies kingdom.
    Bhadra U; Patra P; Chhatai J; Pal-Bhadra M
    Mol Med; 2016 Dec; 22():759-775. PubMed ID: 27704139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of microRNAs: current status and future challenges.
    Li Z; Rana TM
    Nat Rev Drug Discov; 2014 Aug; 13(8):622-38. PubMed ID: 25011539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
    He L; Xie M; Huang J; Zhang T; Shi S; Tang T
    Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small non-coding RNA therapeutics for cardiovascular disease.
    Shah AM; Giacca M
    Eur Heart J; 2022 Nov; 43(43):4548-4561. PubMed ID: 36106499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
    Yan B; Wang H; Tan Y; Fu W
    Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: control and loss of control in human physiology and disease.
    Li M; Marin-Muller C; Bharadwaj U; Chow KH; Yao Q; Chen C
    World J Surg; 2009 Apr; 33(4):667-84. PubMed ID: 19030926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations.
    Hemida MG; Ye X; Thair S; Yang D
    Mol Diagn Ther; 2010 Oct; 14(5):271-82. PubMed ID: 21053993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as novel endogenous targets for regulation and therapeutic treatments.
    Cha W; Fan R; Miao Y; Zhou Y; Qin C; Shan X; Wan X; Cui T
    Medchemcomm; 2018 Mar; 9(3):396-408. PubMed ID: 30108932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.
    Fan R; Xiao C; Wan X; Cha W; Miao Y; Zhou Y; Qin C; Cui T; Su F; Shan X
    RNA Biol; 2019 Jun; 16(6):707-718. PubMed ID: 30900502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA therapeutics: principles, expectations, and challenges.
    Rupaimoole R; Han HD; Lopez-Berestein G; Sood AK
    Chin J Cancer; 2011 Jun; 30(6):368-70. PubMed ID: 21627858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges.
    Bernardo BC; Gregorevic P; Ritchie RH; McMullen JR
    Front Pharmacol; 2018; 9():1090. PubMed ID: 30298011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?
    La Sala L; Carlini V; Conte C; Macas-Granizo MB; Afzalpour E; Martin-Delgado J; D'Anzeo M; Pedretti RFE; Naselli A; Pontiroli AE; Cappato R
    Pharmacol Res; 2024 Mar; 201():107083. PubMed ID: 38309383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL and microRNA therapeutics in cardiovascular disease.
    Michell DL; Vickers KC
    Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases.
    Saenz-Pipaon G; Dichek DA
    Atherosclerosis; 2023 Jun; 374():44-54. PubMed ID: 36577600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.
    Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A
    Microrna; 2020; 9(3):198-215. PubMed ID: 31686643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.
    Wang J; Liew OW; Richards AM; Chen YT
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.
    Landmesser U; Poller W; Tsimikas S; Most P; Paneni F; Lüscher TF
    Eur Heart J; 2020 Oct; 41(40):3884-3899. PubMed ID: 32350510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets.
    Mian YA; Zeleznik-Le NJ
    Curr Drug Targets; 2010 Jul; 11(7):801-11. PubMed ID: 20370647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.